The Ultimate GLP-1 Guide: Weight Loss, Side Effects & Sarcopenia Risk

Are GLP-1 agonists like Ozempic and Mounjaro the future of healthcare or a risk to your health? We break down the latest data on weight loss medication efficacy, common side effects, and the truth about muscle mass loss (sarcopenia). In This Episode: Dr. Jordan Feigenbaum and Dr. Austin Baraki are joined by obesity medicine expert Dr. Spencer Nadolsky to provide a comprehensive update on the rapid evolution of anti-obesity medications. We dive deep into the clinical efficacy of GLP-1 receptor agonists, comparing Semaglutide (Wegovy) against Tirzepatide (Zepbound) and the emerging triple agonist, Retatrutide. The discussion goes beyond the scale to explore the concept of "food noise" and the profound, weight-independent benefits these drugs offer for cardiovascular health, chronic kidney disease, and fatty liver disease (CKM Syndrome). We also tackle the biggest controversies in the space: Are the risks of pancreatitis and muscle loss real, or are they overblown? Learn how resistance training and protein intake play a vital role in preserving lean mass during treatment. Finally, we discuss the future of oral weight loss drugs, navigating insurance hurdles, and the pros and cons of compounded medications. Timestamps: 0:00 - Introduction & Welcome 5:48 - The Science of GLP-1s & The Incretin Effect 8:06 - Debunking "Nature's Ozempic" & Supplements 14:35 - What is "Food Noise"? 19:43 - Efficacy Data: Semaglutide vs. Tirzepatide 24:50 - The Future Pipeline: Retatrutide (Triple Agonists) 28:04 - Upcoming Oral Weight Loss Options 33:10 - Heart Health & Weight-Independent Benefits 38:12 - Kidney & Liver Disease (CKM Syndrome) 41:47 - Emerging Benefits: Sleep Apnea & Addiction 48:20 - Common Side Effects: Nausea & Gastrointestinal Issues 52:59 - Rare Risks: Pancreatitis & Vision Loss (NAION) 58:36 - The Muscle Loss Controversy: Fact vs. Fiction 1:13:44 - Access, Cost & Insurance Hurdles 1:16:50 - Compounded Medications vs. FDA Approved 1:24:41 - Key Takeaways & Conclusion Resources & Guest Links: Connect with Dr. Austin Baraki and Dr. Spencer Nadolsky: https://joinvineyard.com/ For evidence-based resistance training programs: barbellmedicine.com/training-programs For individualized medical and training consultation: barbellmedicine.com/coaching Explore our full library of articles on health and performance: barbellmedicine.com/resources #GLP1 #Ozempic #WeightLoss #BarbellMedicine #Mounjaro #ObesityMedicine #Health #Fitness #Medicine